Introduction
Piledac Plus is a prescription medication that contains multiple active ingredients, including Lidocaine, Calcium Dobesilate, Hydrocortisone, Phenylephrine, Zinc Oxide, and Troxerutin. This cream is commonly used to provide relief from various skin conditions, such as itching, inflammation, and pain.
Uses
Piledac Plus is primarily prescribed for the treatment of skin conditions, including hemorrhoids, anal fissures, and other inflammatory conditions of the anorectal area. It can also be used to alleviate discomfort caused by itching, swelling, and pain associated with these conditions.
Dosage and Administration
Before applying Piledac Plus, thoroughly clean and dry the affected area. Apply a thin layer of the cream to the affected area and gently massage it into the skin until it is absorbed. It is typically recommended to use the cream two to three times a day, or as directed by your healthcare provider. However, follow the specific instructions provided by your healthcare professional, as the dosage and frequency may vary depending on the severity of your condition.
Mechanism of Action
Piledac Plus contains several active ingredients that work together to provide relief from symptoms. Lidocaine is a local anesthetic that helps to numb the area and reduce pain. Calcium Dobesilate helps to improve blood circulation, reducing inflammation and swelling. Hydrocortisone is a corticosteroid that helps to reduce itching and inflammation. Phenylephrine is a vasoconstrictor that helps to shrink blood vessels, reducing swelling and pain. Zinc Oxide has a protective and drying effect on the skin. Troxerutin helps to strengthen blood vessels and reduce inflammation.
Side Effects
Common side effects may include mild skin irritation, redness, or a burning sensation at the application site. These side effects are usually temporary and should subside on their own. However, if you experience any severe or persistent side effects, such as severe skin irritation, rash, or allergic reactions, seek medical attention immediately.
Drug Interactions
Piledac Plus may interact with certain medications. Inform your healthcare provider about all the medications you are currently taking, including prescription and over-the-counter medications, as well as any herbal supplements. They can determine if there are any potential interactions that may affect the safety or effectiveness of Piledac Plus.
Precautions
Before using Piledac Plus, inform your healthcare provider if you have any known allergies to the active ingredients or any other substances. Additionally, inform your healthcare provider about any existing medical conditions, as well as any medications or supplements you are taking. This will help your healthcare provider ensure the safe and appropriate use of Piledac Plus.
Storage
Patient Tips
- Wash your hands before and after applying the cream to avoid spreading infection.
- Avoid getting the cream in your eyes, nose, mouth, or any open wounds.
- If you accidentally swallow the cream, seek medical attention immediately.
- If your symptoms do not improve or worsen after using Piledac Plus, contact your healthcare provider.
- Do not use Piledac Plus for a prolonged period without medical supervision.
- If you are pregnant or breastfeeding, consult your healthcare provider before using this medication.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Vitamins and minerals – Calcium (NHS UK) [Accessed 28 Jun. 2024] (online) Available at:
- CLINIMIX N14G30E, solution for infusion (Health Professionals SmPC) Available at:
- Calcium acetate (Drugs.com) [Accessed 6 Jun. 2024] (online) Available at:
- calcium acetate (RX) [Accessed 23 Jun. 2024] (online) Available at:
- Calcium Acetate (MedlinePlus) [Accessed 0 Jun. 2024] (online) Available at:
- Wang Y, Xie G, Huang Y, Zhang H, Yang B, Mao Z. Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis. PLoS One. 2015 Mar 23;10(3):e0121376. doi: 10.1371/journal.pone.0121376. eCollection 2015. [Accessed 29 Jun. 2024] Available at:
Reviews
There are no reviews yet.